Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.
S. Boyer, M. L. Nishimwe, Luis Sagaon-Teyssier, L. March, S. Koulla-Shiro, Marwân-Al-Qays Bousmah, R. Toby, Mireille Mpoudi-Etame, Ndeye Fatou Ngom Gueye, A. Sawadogo, Charles Kouanfack, L. Ciaffi, Bruno Spire, Eric Delaporte, Avelin Aghokeng Fobang